Beatriz Merino

Dr. Beatriz Merino

Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Pablo, CEU Universities, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
ÓNÓscar Nogales
Óscar Nogales
JGJavier García-Lledó
Javier García-Lledó
MLMarisol Luján
Marisol Luján
DNDavid Nicolás
David Nicolás
JJJosé Francisco Juanmartiñena
José Francisco Juanmartiñena
CACecilia González Asanza
Cecilia González Asanza
Colon capsule endoscopy (CCE) is an alternative approach for the examination of the colon in patients who refuse colonoscopy or after incomplete colonoscopy (IC). We conducted a study to determine the frequency of complete colonoscopy after IC, the diagnostic yield of CCE, the therapeutic impact of lesions found in CCE, the level of colon cleanliness and the safety of the procedure. We performed a prospective, multicenter study involving ten Spanish hospitals. Consecutive outpatients aged ≥ 18 years with previous IC were invited to participate. The latest version of the CCE device, PillCam™ COLON 2 (CCE-2), was administered to all patients according to the protocol. The study population comprised 96 patients. The most frequent cause of IC was the inability to move past a loop using standard maneuvers (75/96 patients, 78%). Complete visualization of the colon was obtained with CCE-2 in 69 patients (71.9%). Of the 27 patients in whom the CCE-2 did not reach the hemorrhoidal plexus, it passed the colonic segment explored with the previous colonoscopy in 20 cases; therefore, it could be inferred that a combined approach (CCE-2 plus colonoscopy) enabled complete visualization of the colonic mucosa in 92.7% of patients. CCE-2 revealed new lesions in 58 patients (60.4%). Polyps were the most frequent finding (41 patients; 42.7% of the total number of patients). In 43 of the 58 patients (44.8% of the total number of patients), the new lesions observed led to modification of therapy, which included a new colonoscopy for polyp resection or surgery in patients with colonic neoplasm. CCE-2 is a suitable diagnostic procedure that can lead to more frequent diagnosis of significant colonic lesions after IC.

23 April 2019 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
APAdrian Plaza
Adrian Plaza
Beatriz MerinoBeatriz Merino
Beatriz Merino
NONuria Del Olmo
Nuria Del Olmo
MRMariano Ruiz-Gayo
Mariano Ruiz-Gayo
Background and Purpose A cholecystokinin (CCK) system has been identified in white adipose tissue (WAT). Nevertheless, the endocrine actions of CCK on WAT remain unknown. Our goal was to investigate the role of CCK in regulating the production of adiponectin, an adipokine expressed in WAT, which is pivotal in preserving energy homeostasis. Experimental Approach The effect of the bioactive CCK fragment CCK‐8 on adiponectin production was studied both in vivo and in vitro. CCK‐8 effects were characterized in rats treated with selective CCK1 and CCK2 receptor antagonists as well as in pre‐adipocytes carrying the selective silencing of either CCK1 or CCK2 receptors. The influence of insulin on CCK‐8 responses was also analysed. Key Results In WAT, CCK‐8 increased plasma adiponectin levels and the expression of the adiponectin gene (Adipoq ). In pre‐adipocytes, CCK‐8 up‐regulated adiponectin production. CCK‐8 effects were abolished by L‐365,260, a selective CCK2 receptor antagonist. CCK2 receptor knockdown also abolished the effects of CCK‐8 in pre‐adipocytes. Moreover, in vitro CCK‐8 effects were blocked by triciribine, a specific inhibitor of protein kinase B (Akt) and by the PPARγ antagonist T0070907. Silencing the expression of the insulin receptor inhibited CCK‐8‐induced Adipoq expression in pre‐adipocytes. Furthermore, insulin potentiated the effect of CCK‐8. Conclusion and Implications CCK‐8 stimulates adiponectin production in WAT by acting on CCK2 receptors, through a mechanism involving both Akt and PPARγ. Moreover, CCK‐8 actions are only observed in the presence of insulin. Our results could have translational value in the design of new insulin‐sensitizing therapies.

1 August 2019 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
APAdrian Plaza
Adrian Plaza
VNVíctor Naranjo
Víctor Naranjo
ABAlessandra M. Blonda
Alessandra M. Blonda
VCVictoria Cano
Victoria Cano
CGCarmen González-Martín
Carmen González-Martín
Beatriz MerinoBeatriz Merino
Beatriz Merino

5 December 2022 in Neuroscience Letters
Verified
Journal Article
Closed access
JFJesús Fernández-Felipe
Jesús Fernández-Felipe
LLLucía L. López
Lucía L. López
VCVictoria Cano
Victoria Cano
ESEnrique Sánchez-Hita
Enrique Sánchez-Hita
ASA. Belén Sanz
A. Belén Sanz
Beatriz MerinoBeatriz Merino
Beatriz Merino

22 April 2022 in British Journal of Pharmacology
Verified
Journal Article
Closed access
APAdrian Plaza
Adrian Plaza
Beatriz MerinoBeatriz Merino
Beatriz Merino
MRMariano Ruiz-Gayo
Mariano Ruiz-Gayo

2 August 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
JFJesús Fernández-Felipe
Jesús Fernández-Felipe
APAdrian Plaza
Adrian Plaza
GDGema Domínguez
Gema Domínguez
Javier Pérez-CastellsJavier Pérez-Castells
Javier Pérez-Castells
Cano VictoriaCano Victoria
Cano Victoria
Beatriz MerinoBeatriz Merino
Beatriz Merino
High-fat diets enriched with lauric acid (SOLF) do not enhance leptin production despite expanding white adipose tissue (WAT). Our study aimed at identifying the influence of SOLF vs. oleic acid-enriched diets (UOLF) on the autoparacrine effect of leptin and was carried out on eight-week-old mice consuming control chow, UOLF or SOLF. Phosphorylation of kinases integral to leptin receptor (LepR) signalling pathways (705Tyr-STAT3, 473Ser-Akt, 172Thr-AMPK), adipocyte-size distribution, fatty acid content, and gene expression were analyzed in WAT. SOLF enhanced basal levels of phosphorylated proteins but reduced the ability of leptin to enhance kinase phosphorylation. In contrast, UOLF failed to increase basal levels of phosphorylated proteins and did not modify the effect of leptin. Both SOLF and UOLF similarly affected adipocyte-size distribution, and the expression of genes related with adipogenesis and inflammation. WAT composition was different between groups, with SOLF samples mostly containing palmitic, myristic and lauric acids (>48% w/w) and UOLF WAT containing more than 80% (w/w) of oleic acid. In conclusion, SOLF appears to be more detrimental than UOLF to the autoparacrine leptin actions, which may have an impact on WAT inflammation. The effect of SOLF and UOLF on WAT composition may affect WAT biophysical properties, which are able to condition LepR signaling.